Top Markets
#1 Verus Coin Verus Coin +45.29%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.62%
#3 Status Status +18.18%
#4 GoPlus Security GoPlus Security +16.88%
#5 Wrapped NXM Wrapped NXM +14.96%
#6 Ontology Gas Ontology Gas +12.84%
#7 Bedrock Bedrock +12.01%
#8 Pons Pons +8.83%
#9 DMT-NAT DMT-NAT +8.72%
#10 BankrCoin BankrCoin +7.39%
Coin of the day
Verus Coin Verus Coin
설정
언어
한국어
통화
USD
테마
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock

Cadrenal Therapeutics, Inc. Common Stock

CVKD
주식 순위 #33958
Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise... Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent that has received orphan drug designation. This treatment is engineered to prevent systemic thromboembolism originating from cardiac issues in patients suffering from both end-stage renal disease and atrial fibrillation. Established in 2022, the firm is headquartered in Ponte Vedra, Florida.
주가
$1.83
마지막 동기화: 2026-08-14
시가총액
$6.53M
변동 (1일)
-1.61%
변동 (1년)
-85.57%
국가
US
거래 Cadrenal Therapeutics, Inc. Common Stock (CVKD)

카테고리

Healthcare
Cadrenal Therapeutics, Inc. Common Stock (CVKD)의 EPS
2026 기준 EPS TTM: 0
Cadrenal Therapeutics, Inc. Common Stock의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 0입니다. 2026년 말에는 회사의 EPS가 0였으며, 이는 2026년의 EPS 0와 동일입니다.
Cadrenal Therapeutics, Inc. Common Stock의 EPS 기록 (2026 ~ 2026)
매년 말의 EPS
연도 EPS 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE